Mayville Engineering Company, Inc. (MEC)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.21	0.21	0.67	0.13	0.12	0.12
Cash & Short-Term Investments	0.21	0.21	0.67	0.13	0.12	0.12
Cash Growth	-34.39%	-69.34%	429.13%	7.63%	-2.48%	12000.00%
Receivables	55.11	54.54	62.9	65.94	59.37	45.21
Inventory	53.95	54.76	67.78	71.71	70.16	41.37
Prepaid Expenses	4.47	3.44	3.27	3.53	2.92	2.56
Total Current Assets	113.73	112.94	134.62	141.3	132.57	89.25
Property, Plant & Equipment	176.09	185.14	207.98	181.84	120.75	109.27
Goodwill	92.65	92.65	92.65	71.54	71.54	71.54
Other Intangible Assets	48.27	51.73	58.67	43.81	50.76	61.47
Long-Term Deferred Charges	0.79	1.25	-	-	-	-
Other Long-Term Assets	2.22	1.85	2.74	2.09	3.87	7.01
Total Assets	433.75	445.57	496.66	440.58	379.47	338.53
Accounts Payable	46.61	39.12	46.53	53.74	50.12	33.5
Accrued Expenses	10.48	10.9	10.78	32.21	13.97	17.56
Current Portion of Long-Term Debt	0.5	0.5	0.5	-	-	-
Current Portion of Leases	5.41	5.32	5.51	5.25	-	0.63
Current Unearned Revenue	2.54	3.46	3.64	6.14	6.14	1.06
Other Current Liabilities	4.07	5.29	4.76	5.12	7.14	-
Total Current Liabilities	69.6	64.59	71.71	102.45	77.37	52.74
Long-Term Debt	70.66	81.1	149.37	72.24	67.61	45.26
Long-Term Leases	26.06	25.69	29.08	32.68	-	2.06
Long-Term Deferred Tax Liabilities	15.76	16.83	12.61	11.82	8.64	11.89
Other Long-Term Liabilities	4.83	5.6	3.92	3.54	27.58	25.73
Total Liabilities	186.9	193.82	266.68	222.71	181.2	137.68
Additional Paid-In Capital	207.85	207.08	205.37	200.95	197.19	190.79
Retained Earnings	59.01	60.09	34.12	26.27	7.55	15
Treasury Stock	-20.02	-15.41	-9.51	-9.35	-6.46	-4.93
Shareholders' Equity	246.84	251.75	229.98	217.87	198.27	200.86
Total Liabilities & Equity	433.75	445.57	496.66	440.58	379.47	338.53
Total Debt	102.63	112.62	184.46	110.16	67.61	47.94
Net Cash (Debt)	-102.42	-112.41	-183.79	-110.03	-67.49	-47.82
Net Cash Per Share	-4.91	-5.36	-8.88	-5.32	-3.31	-2.40
Filing Date Shares Outstanding	20.32	20.42	20.36	20.17	20.27	20.06
Total Common Shares Outstanding	20.3	20.42	20.31	20.17	20.34	20.06
Working Capital	44.13	48.35	62.91	38.86	55.19	36.51
Book Value Per Share	12.16	12.33	11.32	10.80	9.75	10.01
Tangible Book Value	105.93	107.37	78.66	102.52	75.98	67.86
Tangible Book Value Per Share	5.22	5.26	3.87	5.08	3.74	3.38
Land	2.56	2.56	2.64	1.03	1.03	1.03
Buildings	79.8	79.55	79.68	59.66	56.24	55.17
Machinery	343.25	337.71	321.86	274.05	244.11	219.87
Construction In Progress	2.63	3.26	9.78	26.44	15.44	3.93

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q